Please assess the completion status of the following clinical trial:

Trial Title: Visual Outcomes After Bilateral Surgical Cataract Phacoemulsification: AcrySof Toric IOL Implantation Compared to Monofocal IOL Implantation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* are willing and able to understand and sign an informed consent;~* are willing and able to attend postoperative examinations per protocol schedule;~* are ≥ 21 years of age, of either gender and any race;~* have bilateral, age related, cataracts;~* have planned cataract removal via phacoemulsification with implantation of an intraocular lens (IOL);~* are available to undergo second eye surgery within 6 weeks of the first eye surgery;~* are in good ocular health, with the exception of cataracts;~* are free of disease(s)/condition(s) listed in the Precautions section of the AcrySof Toric and monofocal package inserts: choroidal hemorrhage, chronic severe uveitis, concomitant severe eye disease, extremely shallow anterior chamber, medically uncontrolled glaucoma, microphthalmos, non-age-related cataract, proliferative diabetic retinopathy (severe), severe corneal dystrophy, severe optic nerve atrophy, irregular corneal astigmatism and color vision deficiencies.~* have regular corneal astigmatism;~* qualify for bilateral AcrySof Toric IOLs on the AcrySof Toric Calculator (www.acrysoftoriccalculator.com)~* are able to obtain pupil dilation ≥ 5.0 mm~* are able to read and understand one of the following languages: Dutch, French, German~Exclusion Criteria:~* previous corneal surgery and/or reshaping~* abnormality, disease and/or conditions of the cornea (i.e. keratoconus, corneal dystrophy, keratitis, corneal scar, etc.), which would clinically contra-indicate the implantation of a toric intraocular lens~* planned multiple procedures during cataract/IOL implantation surgery~* planned limbal relaxing incision (LRI), Excimer laser treatment or similar procedure prior to or during the course of the study~* an ocular disease and/or condition that may compromise visual acuity levels (i.e. glaucoma, diabetic retinopathy, amblyopia, etc.)~* pregnant, lactating or planning pregnancy during course of study. Subjects who become pregnant during the study will not be discontinued; however, data may be excluded from the effectiveness analyses because pregnancy can alter refraction and visual acuity results. Data will be collected on the CRF as observations.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Toric T3 - T9 (Type: EXPERIMENTAL): Bilateral implantation of a Toric intraocular lens (IOL) models T3, T4, T5, T6, T7, T8 or T9
- Monofocal (Type: ACTIVE_COMPARATOR): Bilateral implantation of a monofocal intraocular lens (IOL) model with no toric component.

Based on this trial design, predict the completion outcome and termination type (if applicable).